Moleculin Biotech Financial Overview
Moleculin Biotech's market cap is currently $8.29M. The company's EPS TTM is $-17.015; its P/E ratio is -0.07; Moleculin Biotech is scheduled to report earnings on November 17, 2025, and the estimated EPS forecast is $-6.11. See an overview of income statement, balance sheet, and cash flow financials.
